HIGH

Major Pharmaceuticals Gabapentin 100 mg 10-Capsule Recall Nationwide 2025

Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack, distributed nationwide in the United States. The recall cites failed impurities and degradation specifications from routine stability testing, specifically an out-of-spec Highest Unknown Impurity. Consumers and healthcare providers should stop using this product immediately and contact The Harvard Drug集团

Quick Facts at a Glance

Recall Date
October 10, 2025
Hazard Level
HIGH
Brands
Gabapentin, Major Pharmaceuticals, Cardinal Health 107 LLC
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC or your healthcare provider for guidance

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Gabapentin is a prescription medication used to treat nerve pain and seizures. This recall involves a 100 mg capsule sold in 10-count blister packs and distributed nationwide in the US.

Why This Is Dangerous

A stability test identified an out-of-spec Highest Unknown Impurity, prompting the recall due to potential safety risk.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

The recall may disrupt treatment for patients currently using these lots. Patients must stop use and consult a healthcare provider for guidance.

Practical Guidance

How to identify if yours is affected

  1. Review packaging for NDC 0904-6665-61 or 55154-3363-0.
  2. Check Lot numbers: M04989A, M05056A, M05150A, M05312A, M05342A.
  3. Check Expiration dates: 02/2026, 04/2026, 07/2026, 01/2027.
  4. If affected, stop using immediately and do not dispose through regular trash.

Where to find product info

FDA recall enforcement page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0031-2026

What timeline to expect

Recall does not specify refund/replacement timelines. Typically 4-8 weeks for processing disruptions may occur.

If the manufacturer is unresponsive

  • Document all communications with Harvard Drug Group LLC or healthcare providers.
  • If the company is unresponsive, contact your pharmacist or local health department for guidance.
  • Consider filing a complaint with the FDA recall program if needed.

How to prevent similar issues

  • Always verify NDCs, lot numbers, and expiration dates before dispensing medications.
  • Consult healthcare providers before switching brands or manufacturers.
  • Keep a copy of the recall notice and related packaging for reference.

Documentation advice

Keep the original packaging, lot number, expiration date, purchase receipts if available, and all correspondence with the provider or distributor.

Product Details

Product: Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack. Rx only. Distributor: Major Pharmaceuticals, Indianapolis, IN 46268, USA. NDCs: 0904-6665-61 (Blister pack), 55154-3363-0 (Outer Bag). Lot numbers: M04989A, M05056A, M05150A, M05312A, M05342A. Expiration dates: 02/2026, 04/2026, 07/2026, 01/2027. Sold nationwide in the US.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 5 lots listed: M04989A, M05056A, M05150A, M05312A, M05342A
  • NDCs: 0904-6665-61 (Blister pack), 55154-3363-0 (Outer Bag)
  • Exp dates: 02/2026, 04/2026, 07/2026, 01/2027
  • Rx only Gabapentin capsules
  • Nationwide US distribution

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
M04989A
M05056A
M05150A
M05312A
M05342A
+2 more
UPC Codes
0904-6665
0904-6666
0904-6667
+9 more
Affected States
ALL
Report Date
October 29, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more